Brendan Teehan, EVP, COO, Head of Commercial: Acadia Pharmaceuticals ACAD Sell · Filed 23/02/27

Trade details

Type: Insider sale
Amount: $8,657.58
Shares · price: 461 sh · $18.78 a share
Held after: 5,195 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Brendan TeehanEVP, COO, Head of Commercial
Trade date: 23/02/24
Filed: 23/02/27
Days to filing: 3 days

Sold 8.2% of holdings

Share of holding sold: 8.2%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/25~23/03/26

Brendan Teehan's recent trades

Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$173.6K
10,329 sh
$173.6K
Filed 24/11/19
Traded 24/11/19
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$145.7K
9,534 sh
$145.7K
Filed 24/08/20
Traded 24/08/19
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$58.9K
3,477 sh
$58.9K
Filed 24/05/03
Traded 24/05/02
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$45.9K
2,568 sh
$45.9K
Filed 24/04/09
Traded 24/04/08
Brendan TeehanEVP, COO, Head of Commercial
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$92K
5,140 sh
$92K
Filed 24/03/27
Traded 24/03/27